Background Dozens of transplants generated from pluripotent stem cells are currently in
clinical trials. The creation of patient-specific iPSCs makes personalized therapy possible …

Human induced pluripotent stem cells (iPSCs) can be limitlessly expanded and
differentiated into almost all cell types. Moreover, they are amenable to gene manipulation …

Autologous‐induced pluripotent stem cells (iPSCs) may eventually be used in cell
replacement therapies to treat a wide range of diseases and have been touted as a solution …

Tissues derived from induced pluripotent stem cells (iPSCs) are a promising source of cells
for building various regenerative medicine therapies; from simply transplanting cells to …

Human embryonic stem cells (hESCs) can undergo unlimited self-renewal and differentiate
into all cell types in human body, and therefore hold great potential for cell therapy of …

The breakthrough development of induced pluripotent stem cells (iPSCs) raises the prospect
of patient-specific treatment for many diseases through the replacement of affected cells …

Background Induced pluripotent stem cell (iPSC) technology provides new opportunities in
regenerative medicine to generate grafts from donors for transplantation. However …

In the regenerative medicine field, allogenic transplantation of regenerated tissues has been
promoted because autologous transplantation setting is costly and time-consuming to …

Donor-specific induced pluripotent stem cells (iPSCs) offer opportunities for personalized
cell replacement therapeutic approaches due to their unlimited self-renewal potential and …

The breakthrough of induced pluripotent stem cells (iPSCs) has raised the possibility that
patient-specific iPSCs can provide autologous cells for cell therapy without the concern for …